1. Home
  2. POM vs RLYB Comparison

POM vs RLYB Comparison

Compare POM & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.24

Market Cap

26.5M

ML Signal

N/A

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$6.06

Market Cap

28.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POM
RLYB
Founded
2015
2018
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
28.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
POM
RLYB
Price
$0.24
$6.06
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
369.9K
88.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.72
EPS
N/A
N/A
Revenue
N/A
$600,000.00
Revenue This Year
N/A
$17.61
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.22
52 Week High
$6.43
$6.17

Technical Indicators

Market Signals
Indicator
POM
RLYB
Relative Strength Index (RSI) 34.60 88.36
Support Level $0.21 $0.48
Resistance Level $0.27 N/A
Average True Range (ATR) 0.03 0.51
MACD 0.04 0.19
Stochastic Oscillator 73.61 97.51

Price Performance

Historical Comparison
POM
RLYB

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: